Literature DB >> 22205559

Practice-based validation of calcium and phosphorus solubility limits for pediatric parenteral nutrition solutions.

Mark MacKay1, Daniel Jackson, Larry Eggert, Kristie Fitzgerald, Jared Cash.   

Abstract

In an effort to maximize the precipitation-free delivery of calcium and phosphorus to neonates, Fitzgerald and MacKay published in 1986 the results of empirical determination of calcium-phosphate saturation curves for a number of parenteral nutrition (PN) solutions. The saturation curves generated from these investigations have been used to formulate thousands of PN solutions. The curves were developed testing only calcium and phosphate without other components added to PN solutions. The authors reviewed 38,019 PN orders from 2007-2010 and plotted the calcium and phosphate concentrations for each solution in relation to the published curves to assess the practical validity of the curves. The solutions reviewed were compounded using standard weight ranges for electrolytes, trace minerals, and vitamins. The solutions were evaluated for precipitation using standards for visual compatibility against a black and white background. There were no visual precipitates found in the 38,019 PN solutions. All calcium and phosphorus concentrations plotted below the precipitation limits predicted by the published curves despite a large range of concentrations of electrolytes and minerals. There has always been concern about extrapolating data from solubility curves that were developed empirically from a limited number of test solutions based on the few variables of calcium, phosphorus, amino acid concentration, and presence of cysteine HCl and/or fat emulsion. This experience validates the calcium and phosphorus solubility limits represented by published curves. Moreover, the findings support the concept that principal variables governing calcium and phosphorus precipitation in PN solutions are calcium, phosphorus, amino acid concentrations, temperature, and pH.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22205559     DOI: 10.1177/0884533611426435

Source DB:  PubMed          Journal:  Nutr Clin Pract        ISSN: 0884-5336            Impact factor:   3.080


  5 in total

1.  Unexpected widespread hypophosphatemia and bone disease associated with elemental formula use in infants and children.

Authors:  Luisa F Gonzalez Ballesteros; Nina S Ma; Rebecca J Gordon; Leanne Ward; Philippe Backeljauw; Halley Wasserman; David R Weber; Linda A DiMeglio; Julie Gagne; Robert Stein; Declan Cody; Kimber Simmons; Paul Zimakas; Lisa Swartz Topor; Sungeeta Agrawal; Andrew Calabria; Peter Tebben; Ruth Faircloth; Erik A Imel; Linda Casey; Thomas O Carpenter
Journal:  Bone       Date:  2017-02-04       Impact factor: 4.398

2.  Effects of dietary omega-3 fatty acids on bones of healthy mice.

Authors:  Lorenzo Anez-Bustillos; Eileen Cowan; Maria B Cubria; Juan C Villa-Camacho; Amin Mohamadi; Duy T Dao; Amy Pan; Gillian L Fell; Meredith A Baker; Prathima Nandivada; Ara Nazarian; Mark Puder
Journal:  Clin Nutr       Date:  2018-09-01       Impact factor: 7.324

Review 3.  The Role of Nutrition in the Prevention and Management of Bronchopulmonary Dysplasia: A Literature Review and Clinical Approach.

Authors:  Gustavo Rocha; Hercília Guimarães; Luís Pereira-da-Silva
Journal:  Int J Environ Res Public Health       Date:  2021-06-09       Impact factor: 3.390

4.  Phosphorus bioaccessibility measured in four amino acid-based  formulas using in-vitro batch digestion translates well into phosphorus bioavailability in mice.

Authors:  Sampada Chande; Francina Dijk; Jonathan Fetene; Steven Yannicelli; Thomas O Carpenter; Ardy van Helvoort; Clemens Bergwitz
Journal:  Nutrition       Date:  2021-04-28       Impact factor: 4.893

Review 5.  Importance of Dietary Phosphorus for Bone Metabolism and Healthy Aging.

Authors:  Juan Serna; Clemens Bergwitz
Journal:  Nutrients       Date:  2020-09-30       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.